Cutaneous Toxicity After Chemoradiotherapy and PD‐L1 Inhibition in Two Patients With Esophageal Adenocarcinoma: More Than Meets the Eye
Oncologist - United States
doi 10.1634/theoncologist.2018-0674
Full Text
Open PDFAbstract
Available in full text
Date
March 22, 2019
Authors
Publisher
Alphamed Press